What this means
Researchers are trying to find out whether ovarian hormones are linked to aging and to Alzheimer's risk in women. This is a registered study that is still recruiting, so no results are available yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60 and over
- Where
- 2 sites, including Florida, Minnesota
The science
- Registered title
- Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
- Trial ID
- NCT03821857 ↗
- Phase
- PHASE 4
- Study type
- interventional
- Conditions
- Alzheimer Disease
- What is tested
- 18-F-Flortaucipir
- Sponsor
- Mayo Clinic
- Ages
- 60 Years to no maximum
- Dates
- First posted Jan 30, 2019 · updated Nov 24, 2025
Registry summary
The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.
Sites (2)
- Mayo Clinic, Jacksonville, Florida, United States
- Mayo Clinic, Rochester, Minnesota, United States